A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder / Adriana Feder en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.2 (Febrero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.2 (Febrero) . - pp. 193-202 Título : A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder Tipo de documento: texto impreso Autores: Adriana Feder, Autor ; Sara Costi, Autor ; Sarah B. Rutter, Autor Fecha de publicación: 2021 Artículo en la página: pp. 193-202 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno de estrés postraumático, Ketamina, Midazolam, Trauma Resumen: Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. The authors’ previous proof-of-concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion. Link: ./index.php?lvl=notice_display&id=26873 [artículo] A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder [texto impreso] / Adriana Feder, Autor ; Sara Costi, Autor ; Sarah B. Rutter, Autor . - 2021 . - pp. 193-202. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.2 (Febrero) . - pp. 193-202 Palabras clave: Trastorno de estrés postraumático, Ketamina, Midazolam, Trauma Resumen: Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. The authors’ previous proof-of-concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion. Link: ./index.php?lvl=notice_display&id=26873

A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder / Adriana Feder en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.2 (Febrero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2021 - Vol. 178 - No.2 (Febrero) . - pp.193-202 Título : A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder Tipo de documento: texto impreso Autores: Adriana Feder, Autor ; Sara Costi, Autor ; Sarah B. Rutter, Autor Fecha de publicación: 2021 Artículo en la página: pp.193-202 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno de estrés postraumático, Ketamina, Midazolam, Trauma Resumen: Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. The authors’ previous proof-of-concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion. Link: ./index.php?lvl=notice_display&id=26874 [artículo] A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder [texto impreso] / Adriana Feder, Autor ; Sara Costi, Autor ; Sarah B. Rutter, Autor . - 2021 . - pp.193-202. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.2 (Febrero) . - pp.193-202 Palabras clave: Trastorno de estrés postraumático, Ketamina, Midazolam, Trauma Resumen: Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. The authors’ previous proof-of-concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion. Link: ./index.php?lvl=notice_display&id=26874

---

1 (1 - 2 / 2)